Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience.

Autor:	Bass, Michael B.1 mbass@amgen.com, Yao, Bin2, Hei, Yong-Jiang3, Ye, Yining4, Davis, Gerard J.5, Davis, Michael T.1, Kaesdorf, Barbara A.5, Chan, Sabrina S.5, Patterson, Scott D.6
Zdroj:	PLoS ONE. Oct2014, Vol. 9 Issue 10, p1-11. 11p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu